SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
Affected assets and topics
Why it matters
SCYNEXIS has been granted a 180-day extension by Nasdaq to regain compliance with the minimum bid price requirement, extending the deadline to June 15, 2026.
Expected market reaction
Market impact analysis based on neutral sentiment with 78% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 25259
Original source
JERSEY CITY, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that it has received an additional 180-calendar-day extension from the Nasdaq Stock Market (“Nasdaq”) to regain compliance with the minimum bid price requirement, as outlined in Nasdaq Listing Rule 5550(a)(2). The Company now has until June 15, 2026, to meet the require
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on December 22, 2025. Analysis and insights provided by AnalystMarkets AI.
This model on similar stories
Llama 3.1 8B Instant (Groq) · 33.3% correct across 45 scored calls on equities See the full record